A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)

被引：0

作者：

G. Gallo

R. Pietroletti

E. Novelli

A. Sturiale

R. Tutino

P. Lobascio

R. Laforgia

E. Moggia

M. Pozzo

M. Roveroni

V. Bianco

A. Realis Luc

A. Giuliani

E. Diaco

G. Naldini

M. Trompetto

R. Perinotti

G. Sammarco

机构：

[1] University of Catanzaro,Department of Medical and Surgical Sciences

[2] University of L’Aquila,Proctology Unit, Department of Biotechnological and Applied Clinical Sciences

[3] Biostat Research S.a.S,Proctology and Pelvic Floor Clinical Centre

[4] Cisanello University Hospital,Chirurgia 1

[5] Azienda ULSS 2 Marca Trevigiana,Surgical Unit “M. Rubino” Department of Emergency and Organ Transplantation

[6] Ospedale Regionale Treviso,Department of General Surgery

[7] University Aldo Moro of Bari,Department of General Surgery

[8] Infermi Hospital,Department of Surgery

[9] “Degli Infermi” Hospital,General Surgery Unit

[10] Aosta Hospital,Department of Colorectal Surgery

[11] Cetraro Hospital,General Surgery Unit, Department of Biotechnological and Applied Clinical Sciences

[12] S. Rita Clinic,Department of Health Sciences

[13] San Salvatore Hospital,Department of Medicine, Surgery and Neurosciences, Unit of General Surgery and Surgical Oncology

[14] University of L’Aquila,undefined

[15] Minerva Surgical Service,undefined

[16] University of Catanzaro,undefined

[17] University of Siena,undefined

来源：

Techniques in Coloproctology | 2022年 / 26卷

关键词：

Haemorrhoidal disease; Polidocanol foam; Safety; Sclerotherapy; Bleeding haemorrhoids;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：627 / 636

页数：9

共 44 条

[1] A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
Gallo, G.
Pietroletti, R.
Novelli, E.
Sturiale, A.
Tutino, R.
Lobascio, P.
Laforgia, R.
Moggia, E.
Pozzo, M.
Roveroni, M.
Bianco, V.
Luc, A. Realis
Giuliani, A.
Diaco, E.
Naldini, G.
Trompetto, M.
Perinotti, R.
Sammarco, G.
TECHNIQUES IN COLOPROCTOLOGY, 2022, 26 (08) : 627 - 636
[2] Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial
Gallo, Gaetano
Picciariello, Arcangelo
Pietroletti, Renato
Novelli, Eugenio
Sturiale, Alessandro
Tutino, Roberta
Laforgia, Rita
Moggia, Elisabetta
Pozzo, Mauro
Roveroni, Maurizio
Bianco, Vincenzo
Luc, Alberto Realis
Giuliani, Antonio
Diaco, Elia
Naldini, Gabriele
Trompetto, Mario
Perinotti, Roberto
D'Andrea, Vito
Lobascio, Pierluigi
COLORECTAL DISEASE, 2023, 25 (03) : 386 - 395
[3] A single-center, single-arm, prospective, open-label trial to evaluate the efficacy and safety of percutaneous sclerotherapy with polidocanol for painful venous malformations (SCIRO-2001): study protocol
Uka, Mayu
Sakurai, Jun
Matsui, Yusuke
Iguchi, Toshihiro
Tomita, Koji
Umakoshi, Noriyuki
Munetomo, Kazuaki
Mitsuhashi, Toshiharu
Gobara, Hideo
Hiraki, Takao
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (04) : 746 - 751
[4] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
Kroiss, Matthias
Quinkler, Marcus
Johanssen, Sarah
van Erp, Nielka P.
Lankheet, Nienke
Poellinger, Alexander
Laubner, Katharina
Strasburger, Christian J.
Hahner, Stefanie
Mueller, Hans-Helge
Allolio, Bruno
Fassnacht, Martin
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10) : 3495 - 3503
[5] Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Zhang, Changgong
Chen, Jianhua
Wu, Huijuan
Wang, Jun
Gao, Liying
Zhao, Jun
Sun, Yan
Jia, Zhongyao
Mu, Xinlin
Bai, Chunmei
Wang, Rui
Wu, Kailiang
Liu, Qiang
Shi, Yuankai
CANCER PATHOGENESIS AND THERAPY, 2024, 2 (04): : 268 - 275
[6] Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Chang, Xuting
Zhang, Jie
Jiang, Yuwu
Yao, Bufan
Wang, Jingmin
Wu, Ye
ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
[7] Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
Marty, Francisco M.
Man, Choy Y.
van der Horst, Charles
Francois, Bruno
Garot, Denis
Manez, Rafael
Thamlikitkul, Visanu
Lorente, Jose A.
Alvarez-Lerma, Francisco
Brealey, David
Zhao, Henry H.
Weller, Steve
Yates, Phillip J.
Peppercorn, Amanda F.
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04) : 542 - 550
[8] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Lan, Chunyan
Shen, Jingxian
Wang, Yin
Li, Jundong
Liu, Zhimin
He, Mian
Cao, Xinping
Ling, Jiayu
Huang, Jiaming
Zheng, Min
Zou, Guorong
Yan, Haowen
Liu, Qing
Yang, Fan
Wei, Wei
Deng, Yanhong
Xiong, Ying
Huang, Xin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
[9] Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial
Kong, Fei
Wen, Xiaoyu
Wen, Xiaofeng
Wang, Xiaozhong
Wu, Guicheng
Lin, Shide
Wang, Li
Xing, Huichun
Yan, Xuebing
Zheng, Sujun
Ning, Qin
Wang, Zheng
Zhang, Liaoyun
Lin, Jianmei
Tong, Zhaowei
Huang, Chengyu
Su, Minghua
Tong, Lixin
Jia, Jidong
Xin, Yongning
Zhu, Qingjing
Wang, Jing
Chen, Li
Li, Xiaowen
Wu, Xuegang
Niu, Duan
Liu, Quan
Wei, Wei
Zhang, Yuexin
Li, Guangming
Niu, Junqi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (09) : 2375 - 2382
[10] Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults
Paradis, Erin M.
Tikhonov, Oleg
Cao, Xin
Kharit, Susanna M.
Fokin, Aleksandr
Platt, Heather L.
Banniettis, Natalie
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4177 - 4182

← 1 2 3 4 5 →